Dong Jiajia, Cai Yijing, Chen Ruicong, Du Shanjie, Chen Yongping, Shi Keqing
Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University.
J Nippon Med Sch. 2015;82(4):211-5. doi: 10.1272/jnms.82.211.
Pulmonary sequestration is a type of bronchopulmonary malformation defined as an isolated portion of lung tissue with systemic arterial supply and no bronchial communication. Carbohydrate antigen 19-9 (CA19-9) has been used for diagnosis and follow-up of gastrointestinal tumors. The current study presents a rare case of intralobar pulmonary sequestration associated with the marked elevation of CA19-9. A 39-year-old female patient was admitted to our hospital due to acute liver injury with marked elevation of serum CA19-9 (3,051.1 μmol/mL), and was then diagnosed with intralobar pulmonary sequestration after examination and surgery. After the pulmonary resection, the serum CA19-9 levels decreased to normal ranges. We briefly reviewed the literature on elevated serum CA19-9 levels and pulmonary sequestration since 1988. We found that serum CA19-9 levels are increased not only in patients with digestive tract cancers but also in those with nonmalignant diseases such as pulmonary sequestration.
肺隔离症是一种支气管肺畸形,定义为具有体循环动脉供血且无支气管相通的孤立肺组织部分。糖类抗原19-9(CA19-9)已用于胃肠道肿瘤的诊断和随访。本研究报告了一例罕见的叶内型肺隔离症伴CA19-9显著升高的病例。一名39岁女性患者因急性肝损伤伴血清CA19-9显著升高(3051.1μmol/mL)入院,经检查和手术后被诊断为叶内型肺隔离症。肺切除术后,血清CA19-9水平降至正常范围。我们简要回顾了自1988年以来关于血清CA19-9水平升高与肺隔离症的文献。我们发现,血清CA19-9水平不仅在消化道癌症患者中升高,在肺隔离症等非恶性疾病患者中也会升高。